FDA Drug Recalls

Recalls / Active ingredient / Oxybutynin Chloride

Oxybutynin Chloride

7 FDA drug recalls involving the active ingredient “Oxybutynin Chloride”.

DateClassProductFirm
2023-10-19Class IIOxybutynin Chloride Extended-Release Tablet USP, 10 mg, 100 count bottles Rx Only, Manufactured by: Cadila HeZydus Pharmaceuticals (USA) Inc
2023-10-19Class IIOxybutynin Chloride Extended-Release Tablet USP, 15 mg, 100 count bottles, Rx Only, Manufactured by: Cadila HeZydus Pharmaceuticals (USA) Inc
2023-10-19Class IIOxybutynin Chloride Extended-Release Tablet USP, 5 mg, 100 count bottles, Rx Only, Manufactured by: Cadila HeaZydus Pharmaceuticals (USA) Inc
2023-09-21Class IIOxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 68382-256-01) and b) 500 tablets (Zydus Pharmaceuticals (USA) Inc
2019-03-01Class IIIOxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (AVKARE Inc.
2019-02-21Class IIIOxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett CompanyLannett Company Inc.
2018-12-11Class IIOxybutynin Chloride Tablets, USP, 5 mg, 500-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940,KVK-Tech, Inc.